SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001019056-24-000101
Filing Date
2024-02-20
Accepted
2024-02-20 11:39:47
Documents
2
Group Members
HOCHE PARTNERS PHARMA HOLDING S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A procaps_13da2.htm SC 13D/A 38323
2 EXHIBIT 99.10 ex99_10.htm EX-99.10 15226
  Complete submission text file 0001019056-24-000101.txt   55067
Mailing Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9 RUE DE BITBOURG LUXEMBOURG N4 L-1273 575-371-9280
Procaps Group, S.A. (Subject) CIK: 0001863362 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92922 | Film No.: 24651604
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3A VAL SAINTE CROIX LUXEMBOURG N4 L-1371
Business Address 3A VAL SAINTE CROIX LUXEMBOURG N4 L-1371 352 2744 7303
Hoche Partners Pharma Holding S.A. (Filed by) CIK: 0001884588 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A